These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 34234380)
21. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion. Woolley DE; Tetlow LC Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391 [TBL] [Abstract][Full Text] [Related]
22. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation. Vandooren B; Cantaert T; Noordenbos T; Tak PP; Baeten D Arthritis Rheum; 2008 Mar; 58(3):718-29. PubMed ID: 18311801 [TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor-alpha promotes the expression of osteoprotegerin in rheumatoid synovial fibroblasts. Kubota A; Hasegawa K; Suguro T; Koshihara Y J Rheumatol; 2004 Mar; 31(3):426-35. PubMed ID: 14994384 [TBL] [Abstract][Full Text] [Related]
24. Th17 cytokines regulate osteoclastogenesis in rheumatoid arthritis. Kim KW; Kim HR; Kim BM; Cho ML; Lee SH Am J Pathol; 2015 Nov; 185(11):3011-24. PubMed ID: 26362732 [TBL] [Abstract][Full Text] [Related]
25. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha. Dai SM; Nishioka K; Yudoh K Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886 [TBL] [Abstract][Full Text] [Related]
26. Osteoclast-Associated Receptor (OSCAR) Distribution in the Synovial Tissues of Patients with Active RA and TNF-α and RANKL Regulation of Expression by Osteoclasts In Vitro. Dharmapatni AASSK; Algate K; Coleman R; Lorimer M; Cantley MD; Smith MD; Wechalekar MD; Crotti TN Inflammation; 2017 Oct; 40(5):1566-1575. PubMed ID: 28555364 [TBL] [Abstract][Full Text] [Related]
27. TLR-3 enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis. Kim KW; Cho ML; Oh HJ; Kim HR; Kang CM; Heo YM; Lee SH; Kim HY Immunol Lett; 2009 May; 124(1):9-17. PubMed ID: 19446344 [TBL] [Abstract][Full Text] [Related]
28. Enhancement of SPARC (osteonectin) synthesis in arthritic cartilage. Increased levels in synovial fluids from patients with rheumatoid arthritis and regulation by growth factors and cytokines in chondrocyte cultures. Nakamura S; Kamihagi K; Satakeda H; Katayama M; Pan H; Okamoto H; Noshiro M; Takahashi K; Yoshihara Y; Shimmei M; Okada Y; Kato Y Arthritis Rheum; 1996 Apr; 39(4):539-51. PubMed ID: 8630101 [TBL] [Abstract][Full Text] [Related]
29. Association of systemic and intra-articular osteoclastogenic potential, pro-inflammatory mediators and disease activity with the form of inflammatory arthritis. Ikić M; Jajić Z; Lazić E; Ivčević S; Grubišić F; Marušić A; Kovačić N; Grčević D Int Orthop; 2014 Jan; 38(1):183-92. PubMed ID: 24100919 [TBL] [Abstract][Full Text] [Related]
30. Production of RANKL by Memory B Cells: A Link Between B Cells and Bone Erosion in Rheumatoid Arthritis. Meednu N; Zhang H; Owen T; Sun W; Wang V; Cistrone C; Rangel-Moreno J; Xing L; Anolik JH Arthritis Rheumatol; 2016 Apr; 68(4):805-16. PubMed ID: 26554541 [TBL] [Abstract][Full Text] [Related]
31. Bone destruction in arthritis. Gravallese EM Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii84-6. PubMed ID: 12379632 [TBL] [Abstract][Full Text] [Related]
32. The effect of vascular endothelial growth factor on osteoclastogenesis in rheumatoid arthritis. Kim HR; Kim KW; Kim BM; Cho ML; Lee SH PLoS One; 2015; 10(4):e0124909. PubMed ID: 25894998 [TBL] [Abstract][Full Text] [Related]
33. Reciprocal activation of CD4+ T cells and synovial fibroblasts by stromal cell-derived factor 1 promotes RANKL expression and osteoclastogenesis in rheumatoid arthritis. Kim HR; Kim KW; Kim BM; Jung HG; Cho ML; Lee SH Arthritis Rheumatol; 2014 Mar; 66(3):538-48. PubMed ID: 24574213 [TBL] [Abstract][Full Text] [Related]
34. Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint. Haynes DR; Crotti TN; Loric M; Bain GI; Atkins GJ; Findlay DM Rheumatology (Oxford); 2001 Jun; 40(6):623-30. PubMed ID: 11426018 [TBL] [Abstract][Full Text] [Related]
35. The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells. Kwan Tat S; Pelletier JP; Lajeunesse D; Fahmi H; Lavigne M; Martel-Pelletier J Clin Exp Rheumatol; 2008; 26(2):295-304. PubMed ID: 18565252 [TBL] [Abstract][Full Text] [Related]
36. Osteoarthritis and rheumatoid arthritis pannus have similar qualitative metabolic characteristics and pro-inflammatory cytokine response. Furuzawa-Carballeda J; Macip-Rodríguez PM; Cabral AR Clin Exp Rheumatol; 2008; 26(4):554-60. PubMed ID: 18799084 [TBL] [Abstract][Full Text] [Related]
37. Synovial fluid macrophages are capable of osteoclast formation and resorption. Adamopoulos IE; Sabokbar A; Wordsworth BP; Carr A; Ferguson DJ; Athanasou NA J Pathol; 2006 Jan; 208(1):35-43. PubMed ID: 16278818 [TBL] [Abstract][Full Text] [Related]